PAIM
BSTC

Punch & Associates Investment Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Punch & Associates Investment Management’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-77,101
Closed -$4.07M – 253
2020
Q3 		$4.07M Buy
77,101
+27,146
+54% +$1.68M 0.35% 112
2020
Q2 		$3.06M Buy
+49,955
New +$2.89M 0.28% 128

Other funds holding BSTC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Punch & Associates Investment Management's BSTC Position: Q4 2020 in Review

Punch & Associates Investment Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 77,101 shares — an estimated $4.07M sold.

Punch & Associates Investment Management first reported a position in BSTC in Q2 2020 and held it in 2 quarters. The position peaked at $4.07M in Q3 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • Punch & Associates Investment Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • Punch & Associates Investment Management sold 77,101 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $4.07M.
  • Punch & Associates Investment Management first reported a position in BioSpecifics Technologies Corp. in Q2 2020 and held it in 2 quarters.
  • Punch & Associates Investment Management's BioSpecifics Technologies Corp. position peaked at $4.07M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Punch & Associates Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.